Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.
about
Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP studyNeuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusionInduction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma.Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer.Persistent mobility disability after neurotoxic chemotherapyHaematopoietic growth factors in children with neutropenia.Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.Taxanes: their impact on gynecologic malignancy.Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review."Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183".Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma.Phase I study of paclitaxel by three-hour infusion: hypotension just after infusion is one of the major dose-limiting toxicities.A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology Group.New Agents in the Management of Non-Small Cell Lung Cancer.
P2860
Q28359347-87ACEBA5-BFE7-4839-BFE0-1048FC39A777Q28379571-9BE2CA8F-C6BF-4E31-9675-E6482148FCF0Q33335541-00E9D4A3-011E-43D7-8AD3-60CDF9E0A5B8Q33340192-F9611D2A-F6BC-4A4F-86B5-5E265936F081Q33381874-C52C1CF5-A75D-4CE8-8469-0A6EF908254CQ33498535-9B55D814-4FCE-4131-B1A4-980F96085ECAQ34194773-D1AC581E-6B05-4BCC-B0FA-CF11CE8F8973Q34207279-0AFE9E95-F239-411D-9FEB-CE12E3623551Q34259315-3BC97821-7B45-4EFF-A94E-15E6E96D60EBQ34527650-83BA4524-D36E-48AD-9149-9C6D2C209DFCQ36136075-B0CFA9B1-6876-481E-92DF-88D96314224DQ37692801-80879B6C-FA38-4DB2-8326-4CA97DFDDD1DQ38726616-C7497030-60AA-4B60-B0D3-06F5430313D5Q38970000-5804EDA2-31D1-49AF-B659-F64F80B60FFEQ40754620-239DFB6D-63AC-48D8-A7A4-D6DBB01D55FDQ42556376-351E2862-CAD7-4BB5-A764-7DB51AF359C5Q45984305-D0790F82-BFA5-4840-90D2-42CFD25B25F6Q47620441-F561D493-F51E-4B09-942D-1653E4FCD1BB
P2860
Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Phase I trial of 3-hour infusi ...... patients with advanced cancer.
@en
Phase I trial of 3-hour infusi ...... patients with advanced cancer.
@nl
type
label
Phase I trial of 3-hour infusi ...... patients with advanced cancer.
@en
Phase I trial of 3-hour infusi ...... patients with advanced cancer.
@nl
prefLabel
Phase I trial of 3-hour infusi ...... patients with advanced cancer.
@en
Phase I trial of 3-hour infusi ...... patients with advanced cancer.
@nl
P2093
P1476
Phase I trial of 3-hour infusi ...... patients with advanced cancer.
@en
P2093
C Feierabend
J H Schiller
R Arzoomanian
P304
P356
10.1200/JCO.1994.12.2.241
P407
P577
1994-02-01T00:00:00Z